Back to User profile » Prof. Dr. Lucio Crinò
Papers published by Prof. Dr. Lucio Crinò:
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
Canale M, Virga A, Angeli D, Fonzi E, Gnetti L, Dubini A, Tedaldi G, Urbini M, Bocchialini G, Petracci E, Verlicchi A, Cravero P, Citarella F, Bennati C, Andrikou K, Delmonte A, Crinò L, Carbognani P, Ulivi P, Ampollini L
Lung Cancer: Targets and Therapy 2025, 16:85-96
Published Date: 28 June 2025
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
Canale M, Urbini M, Petracci E, Angeli D, Tedaldi G, Priano I, Cravero P, Flospergher M, Andrikou K, Bennati C, Tassinari D, Dubini A, Rossi G, Panzacchi R, Valli M, Bronte G, Crinò L, Delmonte A, Ulivi P
Lung Cancer: Targets and Therapy 2025, 16:11-23
Published Date: 20 February 2025
Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]
Ricciuti B, Genova C, Crinò L, Libra M, Leonardi GC
OncoTargets and Therapy 2020, 13:3975-3976
Published Date: 11 May 2020
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies
Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI
Lung Cancer: Targets and Therapy 2019, 10:125-130
Published Date: 13 November 2019
Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence
Ricciuti B, Genova C, Crinò L, Libra M, Leonardi GC
OncoTargets and Therapy 2019, 12:3171-3179
Published Date: 30 April 2019
Targeting RET-rearranged non-small-cell lung cancer: future prospects
Bronte G, Ulivi P, Verlicchi A, Cravero P, Delmonte A, Crinò L
Lung Cancer: Targets and Therapy 2019, 10:27-36
Published Date: 20 March 2019